Elisabeth Erhardtsen
Overview
Explore the profile of Elisabeth Erhardtsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erhardtsen E, Rasmussen D, Frederiksen P, Leeming D, Shevell D, Gluud L, et al.
JHEP Rep
. 2021 Sep;
3(4):100317.
PMID: 34466796
Background & Aims: Progressive fibrosis has been identified as the major predictor of mortality in patients with non-alcoholic fatty liver disease (NAFLD). Several biomarkers are currently being evaluated for their...
2.
Tecson K, Erhardtsen E, Eriksen P, Gaber A, Germain M, Golestaneh L, et al.
BMJ Open
. 2017 Jul;
7(7):e016028.
PMID: 28698338
Objectives: To determine the optimal threshold of blood and urine neutrophil gelatinase-associated lipocalin (NGAL) to predict moderate to severe acute kidney injury (AKI) and persistent moderate to severe AKI lasting...
3.
Levy J, Fingerhut A, Brott T, Langbakke I, Erhardtsen E, Porte R
Transfusion
. 2006 Jun;
46(6):919-33.
PMID: 16734808
Background: In recent years, the hemostatic agent recombinant factor VIIa (rFVIIa) has emerged as a potentially new therapeutic agent for management of coagulopathy in patients with cirrhosis or following severe...
4.
Shao Y, Yang J, Chau G, Sirivatanauksorn Y, Zhong S, Erhardtsen E, et al.
Am J Surg
. 2006 Jan;
191(2):245-9.
PMID: 16442954
Background: Coagulopathy caused by cirrhosis may contribute to excessive bleeding during hepatectomy. We evaluated the hemostatic effect and safety of recombinant factor VIIa (rFVIIa) in cirrhotic patients undergoing partial hepatectomy....
5.
Hedner U, Erhardtsen E
Clin Adv Hematol Oncol
. 2005 Oct;
1(2):112-9.
PMID: 16224390
Recombinant factor VIIa (rFVIIa) has been shown to induce hemostasis in hemophilia patients with inhibitors against factor VIII or factor IX independent of factor VIII/factor IX. Factor VIIa binds to...
6.
Planinsic R, van der Meer J, Testa G, Grande L, Candela A, Porte R, et al.
Liver Transpl
. 2005 Jul;
11(8):895-900.
PMID: 16035081
Orthotopic liver transplantation (OLT) can be associated with excessive blood loss. As a result, there may be increased risk of adverse outcomes. Activated recombinant factor VII (rFVIIa) has demonstrated the...
7.
Fridberg M, Hedner U, Roberts H, Erhardtsen E
Blood Coagul Fibrinolysis
. 2005 May;
16(4):259-66.
PMID: 15870545
In this randomized, placebo-controlled, double-blind, single-centre, dose escalation study, we report the first evaluation of the pharmacokinetics and safety of recombinant activated factor VII (rFVIIa) in healthy Caucasian and Japanese...
8.
Lodge J, Jonas S, Oussoultzoglou E, Malago M, Jayr C, Cherqui D, et al.
Anesthesiology
. 2005 Feb;
102(2):269-75.
PMID: 15681939
Background: Prevention of bleeding episodes in noncirrhotic patients undergoing partial hepatectomy remains unsatisfactory in spite of improved surgical techniques. The authors conducted a randomized, placebo-controlled, double-blind trial to evaluate the...
9.
Bosch J, Thabut D, Bendtsen F, DAmico G, Albillos A, Abraldes J, et al.
Gastroenterology
. 2004 Oct;
127(4):1123-30.
PMID: 15480990
Background & Aims: Upper gastrointestinal bleeding (UGIB) is a severe and frequent complication of cirrhosis. Recombinant coagulation factor VIIa (rFVIIa) has been shown to correct the prolonged prothrombin time in...
10.
Sorensen B, Hedner U, Erhardtsen E
Semin Vasc Med
. 2004 Jun;
3(2):199-204.
PMID: 15199483
Following vessel wall injury, tissue factor (TF) is exposed and forms complexes with already activated factor VII (FVIIa) present in the circulating blood, thereby initiating the hemostatic process. After the...